Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) shares fell in early trading yesterday lower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a downgraded rating.
Meanwhile, U.S. stocks edged lower Monday, with major indexes retreating from record levels.
The Dow Jones Industrial Average DJIA, -0.31% fell 48 points, or 0.2%, to 19,916, while the S&P 500 index SPX, -0.29% lost 5 points to 2,272, a drop of 0.2%. The Nasdaq Composite Index COMP, -0.03% rose 4 points to 5,529, a gain of about 0.1%.
Analysts at Mizuho downgraded shares of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) from Neutral to Underperform in a research note to investors today. With a rating of Underperform on the shares, the company has a 52-week high of $88.47. As a means of comparison, a number of other analysts have issued reports on the company recently, and Eagle Pharmaceuticals, Inc. has secured a consensus one-year price target of $92.75, above the opening price of $73.56. considerable and fundamental digressions in the company’s operations, future direction or industry can cause downgrades as the analysts consider that the future prospects for the security have weakened from the initial recommendation.
Yesterday Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) shares last traded at $68.69, a decrease of $6.48 over the previous closing price. Opening at $73.56, they fluctuated from $67.61 and $73.65 throughout the day.
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) now has a market cap of 1.06B.
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Average Daily Trading Volume
272,790 shares traded hands yesterday, 99 percent below the average, out of a total float 8,147,000. lower than normal. Look for trading volume to pick up in the coming days as momentum traders often use upticks in trading volume to identify heavy volume accumulation or distribution by institutional investors.
However, a single day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to watch for institutional sponsorship as a signal that financial institutions are moving forward.
Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.
These instituitional investors have substantial teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Moving Averages
A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.
This is because the average acts like a floor (support), so the price bounces up off of it.
In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.
By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.
Trades for Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) have ranged from $33.02 – 88.47, and the stock now has a 50-day MA of $77.60 and 200-day MA of $62.93. Today’s last price is 22.36%% lower than the 52 week high of $88.47.
Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors identify companies that have increased their earnings at least 25% or more over the past 3 years.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.